Your Skin Is Perpetually Compromised. Here's the Biological Reason.

Filaggrin is a structural protein that acts like the mortar between the bricks of your skin barrier. Your cells produce filaggrin, break it down into amino acids and natural moisturizing factors, and use those to fill gaps between skin cells and maintain hydration. Without functional filaggrin, your barrier is porous, dry, and leaky.

Here’s the problem: loss-of-function variants in FLG, including R501X and 2282del4, impair your cells’ ability to produce or use filaggrin properly. Roughly 10% of people with European ancestry carry these variants. If you carry a loss-of-function FLG variant, your skin barrier is structurally compromised at the cellular level. No amount of moisturizer adds the protein your cells aren’t making.

You experience this as chronically dry skin that doesn’t improve with hydration, persistent eczema or dermatitis, increased sensitivity to irritants, and a barrier that flares unpredictably. Your skin feels tight and reactive because it literally is: the structural integrity is reduced.

Vitamin D receptors sit on the surface of your skin cells and trigger the expression of genes required for barrier repair, immune tolerance, and antimicrobial peptide production. When vitamin D binds to VDR, it essentially tells your skin to build a stronger barrier and calm down immune activation. Without functional VDR signaling, barrier repair stalls and immune dysregulation worsens.

VDR variants like BsmI and FokI are extremely common, occurring in 30 to 50% of the population depending on ancestry. People with reduced-function VDR variants require higher vitamin D levels to activate the same amount of barrier repair as people with fully functional receptors. Standard vitamin D supplementation may not be enough.

You experience this as a barrier that doesn’t heal even with good skincare, persistent low-level inflammation, and seasonal worsening that correlates with reduced sun exposure. If your VDR isn’t working well, winter is brutal for your skin because your cells can’t mount a proper repair response.

MTHFR catalyzes a critical step in the methylation cycle, the biochemical process that produces the methyl groups your cells need to regenerate, build new proteins, and manage inflammation. When MTHFR works well, your skin cells are constantly repairing, regenerating, and replacing damaged barrier components. When MTHFR function is reduced, cellular regeneration slows and inflammation escalates.

The C677T variant in MTHFR, carried by roughly 40% of people with European ancestry, reduces enzyme efficiency by 30 to 70% depending on whether you carry one or two copies. With reduced MTHFR function, your cells are struggling to produce the methyl donors required for barrier protein synthesis and inflammatory regulation. You can eat perfectly and still be biologically unable to rebuild barrier integrity at the speed your skin needs.

You experience this as slow wound healing in the skin, persistent inflammation that doesn’t respond to typical anti-inflammatory treatments, and a barrier that requires constant attention. If your MTHFR is working at 40% efficiency, your skin is essentially operating in a low-energy repair state.

SOD2 is an antioxidant enzyme that sits inside your mitochondria and neutralizes free radicals before they damage your skin cells. When SOD2 works well, your cells are protected from oxidative stress and can maintain barrier integrity even under UV exposure or inflammatory challenge. When SOD2 is underpowered, oxidative damage accumulates, triggering inflammation and accelerating barrier breakdown.

The Val16Ala variant in SOD2 is carried by roughly 40% of the population in homozygous form. People with the Ala/Ala genotype have reduced SOD2 enzyme activity and accumulate oxidative stress in their skin cells much faster than people with Val/Val. This accelerates photoaging, increases inflammatory skin conditions, and makes barriers more fragile.

You experience this as skin that ages faster under sun exposure, persistent redness and sensitivity that worsens with stress or heat, and a barrier that feels thin and reactive. If your SOD2 is underpowered, your skin cells are essentially oxidatively stressed even at baseline.

TNF-alpha is a master inflammatory cytokine that tells your immune system to increase inflammation. In the skin, TNF-alpha drives barrier breakdown, increases skin permeability, triggers mast cell degranulation, and accelerates inflammatory skin diseases like eczema and psoriasis. When TNF-alpha is elevated chronically, your skin barrier is under constant inflammatory assault.

The -308G>A variant in the TNF promoter, carried by roughly 30% of the population, increases TNF-alpha production. People with the A allele produce more TNF-alpha in response to triggers, which means their skin barriers face constant inflammatory pressure even when external triggers are minimal. Your barrier isn’t just structurally compromised; it’s actively being attacked by your own immune system.

You experience this as chronic redness, flares that seem to come from nowhere, heightened reactivity to irritants and allergens, and a barrier that feels like it’s burning or inflamed. If your TNF variant is driving high production, your skin is in a pro-inflammatory state regardless of your skincare.

Interleukin-6 is a pro-inflammatory cytokine that amplifies inflammatory cascades. When TNF-alpha sends an alarm, IL-6 turns up the volume and spreads that inflammatory signal throughout your body and skin. Chronically elevated IL-6 means your skin is stuck in a heightened inflammatory state where even minor irritants trigger excessive responses.

The -174G>C variant in IL6, carried by roughly 40% of the population with the C allele, increases IL-6 production. People with the C/C genotype produce more IL-6 and therefore mount larger inflammatory responses to barrier challenges. Your immune system doesn’t just overreact; it’s genetically wired to amplify and sustain inflammatory signals.

You experience this as chronic low-level inflammation that never fully resolves, flares that last longer than they should, and a barrier that stays sensitized long after the initial trigger. If your IL-6 production is elevated, your skin barrier struggles to exit the inflammatory state once activated.